Company Search:
Advanced Search
Sponsored Links
RegeneRx Biopharmaceuticals, Inc. Company Snapshot
RegeneRx Biopharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares RegeneRx Biopharmaceuticals with three other companies in this sector in the United States: Regen Biopharma Inc (2016 sales of $100,000.00 ), Boston Therapeutics Inc ($98,878.00 of which 100% was Sugardown TM), and Cara Therapeutics Inc ($86,000.00 of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
RegeneRx Biopharmaceuticals, Inc.
  Stock Performance Chart for RegeneRx Biopharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .27
(Figures in U.S. Dollars)
1 Week 20.5%   13 Weeks 76.7%  
4 Weeks -19.7%   52 Weeks -20.5%  
RegeneRx Biopharmaceuticals, Inc. Key Data:
  Ticker: RGRX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 93,308
(Year Ending Jan 2017).
Employees: 5
  Currency: U.S. Dollars Market Cap: 29,094,271
  Fiscal Yr Ends: December Shares Outstanding: 109,789,703
  Share Type: Common Closely Held Shares: 55,896,330
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.